John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
3M
MMM
$92.5B
| $1.83M | ﹤0.01% |
12,477
+25
| +0.2% | +$3.67K |
|
1727
Exponent
EXPO
$3.33B
| $1.83M | ﹤0.01% |
22,598
+18,488
| +450% | +$1.61M |
|
|
ATSG
1728
DELISTED
Air Transport Services Group
ATSG
| $1.82M | ﹤0.01% |
81,193
-173,510
| -68% | -$3.86M |
|
1729
Coastal Financial
CCB
$721M
| $1.82M | ﹤0.01% |
20,097
-23,584
| -54% | -$2.06M |
|
|
BKHA
1730
Black Hawk Acquisition Corp
BKHA
| $1.82M | ﹤0.01% |
172,500
| – | – |
|
1731
Innodata
INOD
$1.97B
| $1.82M | ﹤0.01% |
50,579
-83,077
| -62% | -$3.65M |
|
|
ALEX
1732
DELISTED
Alexander & Baldwin
ALEX
| $1.81M | ﹤0.01% |
105,197
+43,436
| +70% | +$768K |
|
1733
Sprout Social
SPT
$648M
| $1.81M | ﹤0.01% |
82,333
-32,033
| -28% | -$931K |
|
|
ZEUS
1734
DELISTED
Olympic Steel
ZEUS
| $1.81M | ﹤0.01% |
57,423
+39,556
| +221% | +$1.33M |
|
1735
TTM Technologies
TTMI
$11.8B
| $1.81M | ﹤0.01% |
88,246
-8,819
| -9% | -$213K |
|
1736
Ironwood Pharmaceuticals
IRWD
$725M
| $1.8M | ﹤0.01% |
1,227,196
+363,768
| +42% | +$866K |
|
1737
Danaos Corp
DAC
$2.78B
| $1.8M | ﹤0.01% |
23,095
-14,036
| -38% | -$1.13M |
|
1738
GlobalFoundries
GFS
$25.2B
| $1.8M | ﹤0.01% |
48,760
-167,746
| -77% | -$6.78M |
|
1739
CVRx
CVRX
$89.8M
| $1.8M | ﹤0.01% |
147,128
+91,761
| +166% | +$1.3M |
|
1740
S&T Bancorp
STBA
$1.76B
| $1.8M | ﹤0.01% |
+48,454
| New | +$1.86M |
|
1741
Ginkgo Bioworks
DNA
$508M
| $1.79M | ﹤0.01% |
314,223
-331,139
| -51% | -$3.37M |
|
|
1742
Progressive
PGR
$129B
| $1.79M | ﹤0.01% |
6,322
-931,705
| -99% | -$244M |
|
|
SFD
1743
Smithfield Foods
SFD
$8.76B
| $1.79M | ﹤0.01% |
+87,568
| New | +$1.79M |
|
1744
Quest Diagnostics
DGX
$27B
| $1.78M | ﹤0.01% |
10,539
-11,350
| -52% | -$1.86M |
|
1745
Stellantis
STLA
$19.8B
| $1.78M | ﹤0.01% |
158,787
-1,063,299
| -87% | -$13.7M |
|
1746
Moelis & Co
MC
$5.04B
| $1.78M | ﹤0.01% |
+30,495
| New | +$2.15M |
|
1747
AB InBev
BUD
$155B
| $1.78M | ﹤0.01% |
28,900
-277,565
| -91% | -$15.2M |
|
|
DESP
1748
DELISTED
Despegar.com
DESP
| $1.78M | ﹤0.01% |
94,679
-474,108
| -83% | -$9.1M |
|
1749
Methode Electronics
MEI
$570M
| $1.78M | ﹤0.01% |
278,657
-108,561
| -28% | -$1.07M |
|
1750
First Financial Corp
THFF
$942M
| $1.78M | ﹤0.01% |
36,253
+2,131
| +6% | +$105K |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.